Medical Swabs Market 2020 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2027 Available at Fortune Business Insights
The global " medical swabs market ” is estimated to rise remarkably on account of the increasing application of cotton for drawing infection samples from the patient by having the least possibility of contact. According to a recently published report by Fortune Business Insights titled, “Medical Swabs Market Size, Share &COVID-19 Impact Analysis, By Type (Cotton Tipped Swab, Foam Tipped Swab, Non-woven, and Others), By Application (Specimen Collection, Disinfection, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027,” the value of this market was USD 2.34 billion in 2019 and is expected to reach USD 4.00 billion by the end of 2027. The market is expected to rise at a CAGR of 6.9% between 2020 and 2027.
Request a Sample Copy of the Research Report:
The Report Answers the Following Questions:
· What is the nature of this market and who are the key players?
· Which segment will lead this market and why?
· What is the impact of COVID-19 pandemic on this market?
· Which are the major industry developments of this market?
North America Dominated Market with Increasing Demand for Continuous Diagnostic Procedures
Region-wise, the global medical swabs market is classified into Latin America, Asia Pacific, North America, and Europe. These regions are further categorized on the basis of nations. Among these, North America generated a revenue of USD 0.97 billion in the year 2019 and emerged dominant. This is accountable to the growing prevalence of infectious diseases that demand continuous diagnostic processes. On the other side, the increasing awareness about the need to get diagnosed for infectious diseases is likely to help Europe market rise at a notable CAGR in the forecast period. Furthermore, the Asia Pacific market is likely to showcase a healthy CAGR with the increasing number of coronavirus testing facilities.
Drivers & Restraints-
The increasing prevalence of COVID-19 Pandemic to Aid in Expansion of Market
Swabs have been used by the medical sector for collecting samples for research activity or for diagnosing any disease. With the use of swab, there is minimum risk of infection contraction between a patient and the sample collector. This hygiene-friendly feature stands as a key factor promoting the medical swabs market growth. Besides this, the increasing prevalence of coronavirus pandemic is further propelling the overall growth of the market. Additionally, the rise in cases of other infectious and communicable diseases will add impetus to the market in the forecast period.
On the contrary, the supply shortage of sterile swabs used in testing processes during the current coronavirus pandemic may cause major hindrance to the market in the coming years. Nevertheless, the increasing number of diseases resulting in hospital stay is further propelling the demand for medical swabs, thereby creating lucrative growth opportunities for the market in the coming years.
For more information visit : https://www.fortunebusinessinsights.com/medical-swabs-market-103318
Puritan Medical Products will Lead Market with Robust Portfolio
The competitive landscape of the global market for medical swabs is highly fragmented in nature witnessing the presence of both small and large scale industries. The market is dominated by Puritan Medical Products on account of its robust portfolio inclusive of products as polyester swabs, non-woven swabs, cotton tipped swab, and others. Other companies operating in this market are focusing on adopting strategies that will help them expand their geographical presence to other regions.
Notable Industry Developments of the Marketfor Medical Swabs Include:
April 2020 – Origin and Stratasys entered into a joint venture for the promotion and distribution of 3D printed nasopharyngeal swabs produced by Origin.
April 2020 – The launch of Q-tip, a polyester swab manufactured by Cleveland Company, was approved by the U.S. Food and Drug Administration with the objective of maximizing the production capacity for continuous supply during the coronavirus pandemic.
Some of the Key Players of thisMarket include:
· FL MEDICAL srl (Italy, Europe)
· Advacare Pharma (Maharashtra, India)
· Puritan Medical Products (Maine, U.S)
· Dynarex (New York, U.S)
· BD (New Jersey, U.S)
· DLS Medical (U.K, Europe)
· 3M (Minnesota, U.S)
· FL MEDICAL srl (Italy, Europe)
· Copan Diagnostics Inc. (Italy, Europe)
Dermatophytic Onychomycosis Treatment Market 2020 Global Industry Size, Revenue Growth Development, Business Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by Forecast to 2027